We are very pleased to announce that we have earned patents for a method to manufacture immunocyte-containing composition, and cancer-treating composition in Europe: Swiss, German, France, the UK and Italy after Japan, Taiwan, Korea and the US.
The invention is for a method in which mononuclear cells are differentiated into a good balance of NK cells, NKT cells, and T cells and said cells are made to proliferate.
This can be possible to receive cancer immunotherapy with a small amount of blood, and ultimately reduce burdens on patient, in terms of cost, time and the like, to obtain mononuclear cells as compared with the traditional methods such as apheresis.
Patent No.: 2947144
Date of Patent: 2020/9/9